再次经口内镜下肌切开术治疗持续/复发贲门失驰缓症的临床价值
DOI:
作者:
作者单位:

1.南昌大学第四附属医院消化内科;2.复旦大学附属中山医院内镜中心,复旦大学内镜诊疗研究所

作者简介:

通讯作者:

中图分类号:

基金项目:

上海申康医院发展中心临床适宜技术联合开发推广应用项目(SHDC12016203);上海消化内镜工程技术研究中心(16DZ2280900)


The Clinical value of Re-POEM in the treatment of persistent/recurrent achalasia
Author:
Affiliation:

Department of Gastroenterology,The Fourth Affiliated Hospital of Nanchang University

Fund Project:

Shanghai Engineering Technique Research Center of Diagnostic and Therapeutic Endoscopy (16DZ2280900); Shanghai Clinically Suitable Technology Joint Development and Application Project of Shenkang Hospital Development Center(SHDC12016203)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 文章评论
    摘要:

    目的 评估在首次POEM失败后再次经口内镜下肌切开术(再次POEM )作为补救治疗的可行性,安全性和有效性。方法 33例首次POEM后仍出现持续/复发症状的患者(Eckardt 症状评分≥4) 被回顾性地从一个 维护数据库中选择出来,这个数据库中共有2516例贲门失弛缓症患者。主要指标是随访期间症状缓解, Eckardt评分≤3。次要观察指标是手术相关不良事件, 食管下括约肌 (LES) 压力的变化, 以及再次POEM治疗前后的反流症状。结果 所有患者在首次行POEM后平均18.6个月(3~55个月)成功进行了再次POEM。平均手术时间为45.1 min(28~64 min)。通过保守治疗成功地处理了一例黏膜下隧道感染。在平均随访期间36.6个月 (12~58个月), 所有患者达到了症状缓解 。在再次POEM 前平均症状评分为 5.5分(4~8分),处理后平均1.3分(范围:0~3分;P<0.001)。再次POEM后, 平均食管下括约肌压力也从26.0 mmHg下降到9.6 mmHg (P<0.001)。再次POEM的临床反流并发症发生率为33.3%(11/33) 。结论 在首次POEM失败后,再次POEM看起来安全有效,作为一种补救方案,可以使所有患者短期症状缓解并且无严重并发症。

    Abstract:

    Objective To evaluate the feasibility, safety, and efficacy of repeat peroral endoscopic myotomy (Re-POEM) as salvage therapy after initial POEM failure. Methods Thirty-three patients with persistence/recurrence of symptoms after previous POEM (Eckardt symptom score≥4) were retrospectively selected from a maintained database housing a total of 2516 consecutive patients with achalasia. The primary endpoint was symptom relief during follow-up, defined by an Eckardt score of ≤3. Secondary outcome measures were procedure-related adverse events, change in manometric lower esophageal sphincter (LES) pressure, and reflux symptoms before and after Re-POEM. Results All patients underwent successful Re-POEM a mean of 18.6 months (range3–55 months) after execution of their primary POEM procedures. Mean operative time was 45.1 minutes (range 28–64 minutes). One instance of submucosal tunnel infection was successfully managed with conservative treatment. During a mean follow-up period of 36.6months (range 12–58 months), symptom relief was achieved in all patients. The mean symptom score pretreatment was 5.5 (range 4–8), compared with a post-treatment mean of 1.3 (range 0–3;P< 0.001). Mean LES pressure also declined from 26.0 mmHg to 9.6mmHg after Re-POEM (P< 0.001). The overall clinical reflux complication rate of Re-POEM was 33.3%(11/33) Conclusions Re-POEM appears safe and effective as a salvage option after initial POEM failure, conferring short-term symptom relief and being free of serious complications in all patients.

    参考文献
    相似文献
    引证文献
引用本文

黄根,李全林,周平红.再次经口内镜下肌切开术治疗持续/复发贲门失驰缓症的临床价值[J].中华消化内镜杂志,2019,36(11):806-810.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2018-08-21
  • 最后修改日期:2019-10-22
  • 录用日期:2018-12-26
  • 在线发布日期: 2019-11-29
  • 出版日期:
您是第位访问者

通信地址:南京市鼓楼区紫竹林3号《中华消化内镜杂志》编辑部   邮编:210003

中华消化内镜杂志 ® 2024 版权所有
技术支持:北京勤云科技发展有限公司